HK IPO Analytics 1H2020: Highlight of Brokers' and Sectors' Performance, and Insti Book Color
As we regularly analyse deal performance, it is time to look at how the HK IPO markets performed during the first half of 2020. In this note, we...
557 Views
Ocumension Therapeutics IPO: Trading Debut
Ocumension Therapeutics (1477 HK) is a China-based ophthalmic pharmaceutical company dedicated to identifying, developing and commercializing...
499 Views
ECM Weekly (24 May 2020) - NetEase and JD Homecoming, Legend Biotech, Nongfu Spring, Yeahka
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. The talk...
373 Views
Kintor Pharma (å¼ęčÆäø) IPO Trading: Limited Upside Despite Retail Chasing
Kintor Pharma raised HKD 1.7 billion (USD 225 m) from its global offering and will list on the stock exchange tomorrow. In our previous insights,...
298 Views
ECM Weekly (17 May 2020) -Dada Nexus, Kintor Pharma, Yeahka, Archosaur Games
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming...
385 Views